Samejon, Ashlea C.
HRN: 23-83-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2024
AMPICILLIN 250MG (VIAL)
10/04/2024
10/10/2024
IVTT
250mg
Q6h
Urti
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes